(Lys8,Lys9)-Neurotensin (8-13) is a shortened analog enriched with two positively charged lysines, shifting electrostatic balance and receptor interaction patterns. The alterations enhance stability and solubility in aqueous media. This fragment supports studies of neurotensin receptor domains governing short-peptide recognition. Researchers use it to map functional residues within neuropeptide signaling sequences.
CAT No: N06001
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More